Histogen HSTO
$ 0.66
31.6%
Quarterly report 2023-Q3
added 11-09-2023
Histogen Balance Sheet 2011-2024 | HSTO
Annual Balance Sheet Histogen
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-11.9 M | -18.5 M | -6.3 M | -20.4 M | -11.6 M | -2.92 M | -57.1 M | -12.9 M | -8.91 M | -3.16 M | - | - |
Long Term Debt |
5 K | 14 K | 369 K | - | - | 13.2 M | - | 1 M | 1 M | 1 M | - | - |
Long Term Debt Current |
238 K | 127 K | 28 K | 338 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 5.32 M | - | 2.88 M | 25.8 M | 21 M | 1.2 M | 1.06 M | 1 M | - | - |
Total Current Liabilities |
1.23 M | 2.33 M | 2.78 M | 1.64 M | 18.5 M | 28.1 M | 39.6 M | 3.98 M | 4.18 M | 2.82 M | - | - |
Total Liabilities |
5.7 M | 7.06 M | 8.1 M | 1.64 M | 21.4 M | 53.9 M | 60.5 M | 5.19 M | 5.23 M | 3.82 M | - | - |
Deferred Revenue |
19 K | 19 K | 48 K | - | 10.1 M | 14.2 M | 30.9 M | - | - | - | - | - |
Retained Earnings |
-88.3 M | -77.7 M | -62.7 M | -198 M | -187 M | -168 M | -151 M | -121 M | -96.8 M | 11.5 K | - | - |
Total Assets |
19.1 M | 27.2 M | 15 M | 21.8 M | 48.8 M | 81.9 M | 82.3 M | 39.7 M | 38.4 M | 56.9 M | - | - |
Cash and Cash Equivalents |
12.1 M | 18.7 M | 6.76 M | 20.7 M | 11.6 M | 16.1 M | 58.1 M | 13.9 M | 9.91 M | 4.16 M | 4.04 M | 3.07 M |
Book Value |
13.4 M | 20.2 M | 6.91 M | 20.2 M | 27.4 M | 28 M | 21.8 M | 34.5 M | 33.2 M | 53.1 M | - | - |
Total Shareholders Equity |
14.4 M | 21.2 M | 7.86 M | 20.2 M | 27.4 M | 28 M | 21.8 M | 34.5 M | 33.2 M | 53.1 M | -58.3 M | -49.7 M |
All numbers in USD currency
Quarterly Balance Sheet Histogen
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 4.24 M | 3 K | 5 K | 8 K | 9 K | 11 K | 14 K | 15 K | 18 K | 310 K | 369 K | 369 K | 369 K | 369 K | 31 K | 31 K | 31 K | 229 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.41 M | 5.28 M | 5.73 M | 5.7 M | 5.93 M | 5.74 M | 7.54 M | 7.06 M | 7.29 M | 6.84 M | 7.18 M | 8.1 M | 8.1 M | 8.1 M | 8.1 M | 1.84 M | 1.84 M | 1.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 19 K | 48 K | 48 K | 48 K | 48 K | 19 K | 19 K | 2.13 M | 8.15 M | 10.1 M | 10.1 M | 14.4 M | 14.9 M | 14.2 M | 19.5 M | 24.6 M | 14.2 M | 30.9 M | 30.9 M | 30.9 M | 30.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-97.7 M | -93.8 M | -91.7 M | -88.3 M | -85.3 M | -81.7 M | -78.3 M | -77.7 M | -74.5 M | -70.7 M | -67 M | -62.7 M | -62.7 M | -62.7 M | -62.7 M | -43.9 M | -43.9 M | -43.9 M | -198 M | -187 M | -187 M | -187 M | -187 M | -168 M | -168 M | -168 M | -168 M | -151 M | -151 M | -151 M | -151 M | -121 M | -121 M | -121 M | -121 M | -96.8 M | -96.8 M | -96.8 M | -96.8 M | -74.4 M | -74.4 M | -74.4 M | - | - | - | - | - | - | - | - | - |
Total Assets |
5.82 M | 13.5 M | 16.1 M | 19.1 M | 22.2 M | 21 M | 31.5 M | 27.2 M | 27.6 M | 30.8 M | 28.8 M | 15 M | 15 M | 15 M | 15 M | 2.94 M | 2.94 M | 2.94 M | 21.8 M | 48.8 M | 48.8 M | 48.8 M | 48.8 M | 81.9 M | 81.9 M | 81.9 M | 81.9 M | 82.3 M | 82.3 M | 82.3 M | 82.3 M | 39.7 M | 39.7 M | 39.7 M | 39.7 M | 38.4 M | 38.4 M | 38.4 M | 38.4 M | 56.9 M | 56.9 M | 56.9 M | 56.9 M | 8.15 M | 8.15 M | 8.15 M | - | - | - | - | - |
Cash and Cash Equivalents |
4.57 M | 7.26 M | 9.66 M | 12.1 M | 14.6 M | 12.6 M | 17.8 M | 18.7 M | 19.2 M | 23.1 M | 21.7 M | 6.76 M | 6.76 M | 6.76 M | 6.76 M | 2.06 M | 2.06 M | 2.06 M | 20.7 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 58.1 M | 58.1 M | 58.1 M | 58.1 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 9.91 M | 9.91 M | 9.91 M | 9.91 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 4.04 M | 4.04 M | 4.04 M | - | 3.07 M | - | - | - |
Book Value |
4.4 M | 8.26 M | 10.3 M | 13.4 M | 16.3 M | 15.3 M | 24 M | 20.2 M | 20.3 M | 24 M | 21.6 M | 6.91 M | 6.91 M | 6.91 M | 6.91 M | 1.1 M | 1.1 M | 1.1 M | 21.8 M | 48.8 M | 48.8 M | 48.8 M | 48.8 M | 81.9 M | 81.9 M | 81.9 M | 81.9 M | 82.3 M | 82.3 M | 82.3 M | 82.3 M | 39.7 M | 39.7 M | 39.7 M | 39.7 M | 38.4 M | 38.4 M | 38.4 M | 38.4 M | 56.9 M | 56.9 M | 56.9 M | 56.9 M | 8.15 M | 8.15 M | 8.15 M | - | - | - | - | - |
Total Shareholders Equity |
5.44 M | 9.29 M | 10.3 M | 14.4 M | 16.3 M | 15.3 M | 19.7 M | 21.2 M | 20.3 M | 24 M | 21.6 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | -37.1 M | -37.1 M | -37.1 M | 20.2 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 28 M | 28 M | 28 M | 28 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 53.1 M | 53.1 M | 53.1 M | 53.1 M | -58.3 M | -58.3 M | -58.3 M | - | -49.7 M | - | - | - |
All numbers in USD currency